Lack of Association between Statin Use and Angiographic and Clinical Outcomes after Pipeline Embolization for Intracranial Aneurysms

REFERENCES

1. 1.↵
   2. Kavalipati N,
   3. Shah J,
   4. Ramakrishan A, et al

   . Pleiotropic effects of statins. Indian J Endocrinol Metab 2015;19:554–62 doi:10.4103/2230-8210.163106 pmid:26425463

   CrossRefPubMed
2. 2.↵
   2. Puato M,
   3. Zambon A,
   4. Faggin E, et al

   . Statin treatment and carotid plaque composition: a review of clinical studies. Curr Vasc Pharmacol 2014;12:518–26 doi:10.2174/15701611113119990134 pmid:23092412

   CrossRefPubMed
3. 3.↵
   2. Hiroyuki K,
   3. Daida M

   . Impact of intensive lipid lowering therapy on carotid plaque instability assessed by MRI; challenger trial: carotid plaque in human for all evaluations with aggressive rosuvastatin therapy—evaluation by magnetic resonance imaging. J Am Coll Cardiol 2014;63(suppl):A1046 doi:10.1016/S0735-1097(14)61046-9

   CrossRef
4. 4.↵
   2. Yamamoto H,
   3. Ikuta S,
   4. Kobuke K, et al

   . Difference in statin effects on neointimal coverage after implantation of drug-eluting stents. Coron Artery Dis 2014;25:290–95 doi:10.1097/MCA.0000000000000102 pmid:24614628

   CrossRefPubMed
5. 5.↵
   2. Tentzeris I,
   3. Rohla M,
   4. Jarai R, et al

   . Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes. Am J Cardiol 2014;113:1099–104 doi:10.1016/j.amjcard.2013.12.012 pmid:24462073

   CrossRefPubMed
6. 6.↵
   2. Reiff T,
   3. Amiri H,
   4. Rohde S, et al

   . Statins reduce peri-procedural complications in carotid stenting. Eur J Vasc Endovasc Surg 2014;48:626–32 doi:10.1016/j.ejvs.2014.08.010 pmid:25240903

   CrossRefPubMed
7. 7.↵
   2. Kadirvel R,
   3. Ding YH,
   4. Dai D, et al

   . Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology 2014;270:394–99 doi:10.1148/radiol.13130796 pmid:24086073

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Becske T,
   3. Kallmes DF,
   4. Saatci I, et al

   . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68 doi:10.1148/radiol.13120099 pmid:23418004

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Kallmes DF,
   3. Hanel R,
   4. Lopes D, et al

   . International retrospective study of the Pipeline embolization device: a multicenter aneurysm treatment study [published Erratum appears in AJNR Am J Neuroradiol 2015;36:E39–40]. AJNR Am J Neuroradiol 2015;36:108–15 doi:10.3174/ajnr.A4111 pmid:25355814

   Abstract/FREE Full Text
10. 10.↵
    2. Kallmes DF,
    3. Brinjikji W,
    4. Boccardi E, et al

    . Aneurysm Study of Pipeline in an Observational Registry (ASPIRe). Interv Neurol 2016;5:89–99 doi:10.1159/000446503 pmid:27610126

    CrossRefPubMed
11. 11.↵
    2. Alexander MD,
    3. Rebhun JM,
    4. Hetts SW, et al

    . Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis. J Neurointerv Surg 2016;8:466–70 doi:10.1136/neurintsurg-2014-011633 pmid:25795438

    Abstract/FREE Full Text
12. 12.↵
    2. Khan M,
    3. Qureshi AI

    . Factors associated with increased rates of post-procedural stroke or death following carotid artery stent placement: a systematic review. J Vasc Interv Neurol 2014;7:11–20 pmid:24920983

    PubMed
13. 13.↵
    2. Kim JS,
    3. Kim JH,
    4. Shin DH, et al

    . Effect of high-dose statin therapy on drug-eluting stent strut coverage. Arterioscler Thromb Vasc Biol 2015;35:2460–67 doi:10.1161/ATVBAHA.115.306037 pmid:26359512

    Abstract/FREE Full Text
14. 14.↵
    2. Jang JY,
    3. Kim JS,
    4. Shin DH, et al

    . Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis. Atherosclerosis 2015;242:553–59 doi:10.1016/j.atherosclerosis.2015.08.014 pmid:26318104

    CrossRefPubMed
15. 15.↵
    2. Suh Y,
    3. Kim BK,
    4. Shin DH, et al

    . Impact of statin treatment on strut coverage after drug-eluting stent implantation. Yonsei Med J 2015;56:45–52 doi:10.3349/ymj.2015.56.1.45 pmid:25510746

    CrossRefPubMed
16. 16.↵
    2. Uemura S

    . Statins and prevention of stent-related late adverse events. Coron Artery Dis 2014;25:277–78 doi:10.1097/MCA.0000000000000116 pmid:24710353

    CrossRefPubMed
17. 17.↵
    2. Jeger RV,
    3. Brunner-La Rocca HP,
    4. Bertel O, et al

    ; BASKET Investigators. Stent thrombosis after coronary stent implantation: a protective effect of high-dose statin therapy? Cardiology 2013;126:115–21 doi:10.1159/000350822 pmid:23948958

    CrossRefPubMed
18. 18.↵
    2. Spiliopoulos S,
    3. Theodosiadou V,
    4. Katsanos K, et al

    . Long-term clinical outcomes of infrapopliteal drug-eluting stent placement for critical limb ischemia in diabetic patients. J Vasc Interv Radiol 2015;26:1423–30 doi:10.1016/j.jvir.2015.06.034 pmid:26250856

    CrossRefPubMed
19. 19.↵
    2. Artom N,
    3. Montecucco F,
    4. Dallegri F, et al

    . Carotid atherosclerotic plaque stenosis: the stabilizing role of statins. Eur J Clin Invest 2014;44:1122–34 doi:10.1111/eci.12340 pmid:25231921

    CrossRefPubMed
20. 20.↵
    2. Correale M,
    3. Abruzzese S,
    4. Greco CA, et al

    . Pleiotropic effects of statin in therapy in heart failure: a review. Curr Vasc Pharmacol 2014;12:873–84 doi:10.2174/1570161112999141127161508 pmid:25440594

    CrossRefPubMed
21. 21.↵
    2. Szikora I,
    3. Turanyi E,
    4. Marosfoi M

    . Evolution of flow-diverter endothelialization and thrombus organization in giant fusiform aneurysms after flow diversion: a histopathologic study. AJNR Am J Neuroradiol 2015;36:1716–20 doi:10.3174/ajnr.A4336 pmid:26251428

    Abstract/FREE Full Text
22. 22.↵
    2. Park SJ,
    3. Kang SM,
    4. Park DW

    . Dual antiplatelet therapy after drug-eluting stents: defining the proper duration. Coron Artery Dis 2014;25:83–89 doi:10.1097/MCA.0000000000000066 pmid:24322887

    CrossRefPubMed
23. 23.↵
    2. Wang TJ,
    3. Yang YJ,
    4. Xu B, et al

    . Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology. Circ J 2012;76:2561–71 doi:10.1253/circj.CJ-12-0468 pmid:22878407

    CrossRefPubMed
24. 24.↵
    2. Aoki J,
    3. Kozuma K,
    4. Tanabe K, et al

    . Effect of olmesartan on the levels of circulating endothelial progenitor cell after drug-eluting stent implantation in patients receiving statin therapy. J Cardiol 2014;64:435–40 doi:10.1016/j.jjcc.2014.02.029 pmid:24768407

    CrossRefPubMed
25. 25.↵
    2. António N,
    3. Fernandes R,
    4. Soares A, et al

    . Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study. Eur J Clin Pharmacol 2014;70:1181–93 doi:10.1007/s00228-014-1718-6 pmid:25048407

    CrossRefPubMed
26. 26.↵
    2. Aoki T,
    3. Kataoka H,
    4. Ishibashi R, et al

    . Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway. Neurosurgery 2009;64:357–65; discussion 365–66 doi:10.1227/01.NEU.0000336764.92606.1D pmid:19190463

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Aoki T,
    3. Kataoka H,
    4. Ishibashi R, et al

    . Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke 2008;39:1276–85 doi:10.1161/STROKEAHA.107.503086 pmid:18309148

    Abstract/FREE Full Text
28. 28.↵
    2. Tadros RO,
    3. Vouyouka AG,
    4. Chung C, et al

    . The effect of statin use on embolic potential during carotid angioplasty and stenting. Ann Vasc Surg 2013;27:96–103 doi:10.1016/j.avsg.2012.06.007 pmid:23088806

    CrossRefPubMed
29. 29.↵
    2. Jeong HC,
    3. Ahn Y,
    4. Hong YJ, et al

    ; Other Korea Acute Myocardial Infarction Registry Investigators. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein. Int J Cardiol 2013;167:1848–53 doi:10.1016/j.ijcard.2012.04.123 pmid:22592028

    CrossRefPubMed